Skip to main content
. 2012 Feb;56(2):715–724. doi: 10.1128/AAC.00717-11

Table 2.

Population pharmacokinetic parameters and bootstrap results from the final covariate model

Parametera Value
Final model
Bootstrap (n = 1,000)
Estimate RSE (%) Median 2.5th–97.5th percentiles
ka (h−1) 0.8
tlag (h) 1.3 0.1 1.3 1.0–1.6
CL/F (liters/h/50-kg LBW) 134 12 135 85–176
    Effect of pregnancy in non-African Americans or effect of coadministration of oral contraceptives −51 28 −44 −78–−4
CLD-P1/F (liters/h) 401 14 398 235-609
CLD-P2/F (liters/h) 120 15 115 35–208
    Effect of pregnancy in non-African Americans −78 31 −72 −140–29
Vc/F (liters) 456 11 436 189–716
VP1/F (liters) 1,560 29 1,630 925–3,629
VP2/F (liters) 16,100 16 17,400 6,124–31,837
Interindividual variability (CV [%])
    CL/F 36 39 34 16–49
    CLD-P2/F 86 48 86 3–133
    Vc/F 114 29 116 75–161
    VP1/F 60 48 60 0.5–110
Residual error (CV [%]) 32 34 32 18–42
a

Abbreviations: RSE, relative standard error; CV, coefficient of variation; ka, absorption rate constant; tlag, lag time; CL/F, oral clearance; CLD-P1/F, apparent intercompartmental clearance from the central compartment to peripheral compartment 1; CLD-P2/F, apparent intercompartmental clearance from the central compartment to peripheral compartment 2; Vc/F, apparent volume of the central compartment; VP1/F, apparent volume of peripheral compartment 1; VP2/F, apparent volume of peripheral compartment 2.